Aytu BioPharma Inc

NASDAQ:AYTU   3:59:51 PM EDT
2.46
-0.10 (-3.91%)
Earnings Announcements

Aytu Biopharma Says Quarterly Net Revenue Increased 74% Sequentially To $23.5 Million

Published: 09/27/2021 22:00 GMT
Aytu BioPharma Inc (AYTU) - Aytu Biopharma Inc - Quarterly Net Revenue Increased 74% Sequentially to $23.5 Million.
Aytu Biopharma Inc - Net Loss for Q4 $0.81 per Share.
Revenue is expected to be $22.7 Million
Adjusted EPS is expected to be -$0.48

Next Quarter Revenue Guidance is expected to be $27.2 Million
Next Quarter EPS Guidance is expected to be -$0.48

More details on our Analysts Page.